We have located links that may give you full text access.
Choroidal Vascularity in Chronic Central Serous Chorioretinopathy and its association with risk single-nucleotide polymorphisms.
Retina 2023 December 13
PURPOSE: To analyse the choroidal parameters of patients with chronic central serous chorioretinopathy (cCSC), and the association with CSC susceptibility genes.
METHODS: The choroidal vascular index (CVI) was obtained by binarizing spectral domain optical coherence tomography (OCT) enhanced depth images of cCSC patients and healthy age-matched controls. cCSC patients were genotyped for three CSC susceptibility SNPs: rs4844392 (mir-29b-2/CD46), rs1329428 (CFH) and rs2379120 (upstream GATA5).
RESULTS: 103 eyes with cCSC and 53 control eyes were included. There was a significant increase in the sub-foveal choroidal area in in both the affected (2.4 ± 0.6mm2) and fellow (2.2 ± 0.6mm2) eyes of patients with cCSC compared to controls (1.8 ± 0.5mm2, (p<0.0001 and p<0.0001). The CVI was reduced in cCSC patients 63.5 ± 3.1% compared to controls 65.4 ± 2.3% (p<0.001) and also in the affected compared to the fellow eyes 64.6 ± 2.9% (p<0.01). There was a significant association between CVI in the cCSC group and presence of the risk SNP rs2379120 at GATA5 (p<0.01).
CONCLUSION: The relative reduction of CVI in cCSC patients may suggest a persistence of vessel hyper-permeability over dilation in chronic disease. GATA5 is associated with CVI in cCSC patients and therefore, may have a role in choroidal vascularity.
METHODS: The choroidal vascular index (CVI) was obtained by binarizing spectral domain optical coherence tomography (OCT) enhanced depth images of cCSC patients and healthy age-matched controls. cCSC patients were genotyped for three CSC susceptibility SNPs: rs4844392 (mir-29b-2/CD46), rs1329428 (CFH) and rs2379120 (upstream GATA5).
RESULTS: 103 eyes with cCSC and 53 control eyes were included. There was a significant increase in the sub-foveal choroidal area in in both the affected (2.4 ± 0.6mm2) and fellow (2.2 ± 0.6mm2) eyes of patients with cCSC compared to controls (1.8 ± 0.5mm2, (p<0.0001 and p<0.0001). The CVI was reduced in cCSC patients 63.5 ± 3.1% compared to controls 65.4 ± 2.3% (p<0.001) and also in the affected compared to the fellow eyes 64.6 ± 2.9% (p<0.01). There was a significant association between CVI in the cCSC group and presence of the risk SNP rs2379120 at GATA5 (p<0.01).
CONCLUSION: The relative reduction of CVI in cCSC patients may suggest a persistence of vessel hyper-permeability over dilation in chronic disease. GATA5 is associated with CVI in cCSC patients and therefore, may have a role in choroidal vascularity.
Full text links
Related Resources
Trending Papers
Revascularization Strategy in Myocardial Infarction with Multivessel Disease.Journal of Clinical Medicine 2024 March 27
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
Management of Diverticulitis: A Review.JAMA Surgery 2024 April 18
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app